CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Reduxiumdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04525456
NCT04525456N/ACompleted

Changes in the Immune Responses With Reduxium in Healthy Adults

Ogevity Therapeutics, Inc.·interventional·Posted Aug 25, 2020·Updated May 27, 2022

In Brief

A clinical study evaluating Reduxium for Immune Tolerance and Viral Infection. Completed, enrolled 20 participants across 3 sites.

Detailed Summary

Reduxium is a dietary supplement that provides immune support. This natural compound is orally-ingested in the form of droplets in water to boost the immune system and control inflammation. There is not enough data on the mechanism associated with the action of Reduxium or the extent of the immune response increase it produces. In this study, the investigators propose treating a group of healthy volunteers with Reduxium and investigate the utility of this approach in boosting the native and adaptive immune responses that correlate with immune protection. This may form the basis for a future study employing the product in infectious disease patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSingapore

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 25, 2020
Enrollment StartOct 7, 2020
Primary CompletionDec 15, 2020
Study CompletionJan 27, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.9 years ago

Interventions

Reduxiumdietary

Single-centre, one-arm, prospective study of 20 healthy subjects who will be given Reduxium supplementation for 14 days.